Evidence map›Paper›PMID 30587952›Full record

Observational studyInternational journal of chronic obstructive pulmonary disease

Physiological predictors Of peak inspiRatory flow using Observed lung function resultS (POROS): evaluation at discharge among patients hospitalized for a COPD exacerbation.

David B Price, Sen Yang, Simon Wan Yau Ming, Antony Hardjojo, Claudia Cabrera, Andriana I Papaioannou, Stelios Loukides, Vicky Kritikos, Sinthia Z Bosnic-Anticevich, Victoria Carter and 1 more

Open access · goldAbstract readComparative StudyObservational Study
In one paragraph

Observational study in International journal of chronic obstructive pulmonary disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Observational
  3. Article
  4. Article
  5. Exploration of quality criteria for the detection of peak inspiratory flow under different resistance conditions.Technology and health care : official journal of the European Society for Engineering and Medicine · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease.International journal of chronic obstructive pulmonary disease
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 8 countries.

David B PriceObservational and Pragmatic Research Institute Pte Ltd, Singapore, Singapore, dprice@opri.sg.
Sen YangObservational and Pragmatic Research Institute Pte Ltd, Singapore, Singapore, dprice@opri.sg.
Simon Wan Yau MingObservational and Pragmatic Research Institute Pte Ltd, Singapore, Singapore, dprice@opri.sg.
Antony HardjojoObservational and Pragmatic Research Institute Pte Ltd, Singapore, Singapore, dprice@opri.sg.
Claudia CabreraGlobal Medical Affairs, AstraZeneca R and D, Mölndal, Sweden.
Andriana I Papaioannou2nd Respiratory Medicine Department, Medical School, National and Kapodistrian University of Athens, Attikon General Hospital, Athens, Greece.
Stelios Loukides2nd Respiratory Medicine Department, Medical School, National and Kapodistrian University of Athens, Attikon General Hospital, Athens, Greece.
Vicky KritikosWoolcock Institute of Medical Research, Quality Use of Respiratory Medicines Group, School of Medical Sciences, University of Sydney, Glebe, Australia.
Sinthia Z Bosnic-AnticevichWoolcock Institute of Medical Research, Quality Use of Respiratory Medicines Group, School of Medical Sciences, University of Sydney, Glebe, Australia.
Victoria CarterOptimum Patient Care, Cambridge, UK.
Paul M DorinskyPearl - a member of the AstraZeneca Group, Durham, NC, USA.
Observational & Pragmatic Research Institute · SGNational and Kapodistrian University of Athens · GRThe University of Sydney · AUAstraZeneca (Netherlands) · NLKarolinska Institutet · SEUniversity of Aberdeen · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPeak inspiratory flow (PIF) as generated through the resistance of a dry powder inhaler (DPI) device is a critical patient-dependent maneuver impacting the success of DPI medication delivery. Despite its importance, it is not routinely measured in clinical practice. Little is currently known about the relationship, if any, between PIF through DPI devices, routine spirometry and disease outcomes.

aimThe aim of this study was to identify potential predictors of PIF for different DPIs from spirometric parameters and patient characteristics and explore the association between PIF and follow-up events. PATIENTS AND

methodsA retrospective observational study at discharge among patients hospitalized for a COPD exacerbation at Attikon hospital, Athens, Greece. Spirometry was performed using an Easy on-PC™ spirometer. PIF was measured through four DPI resistances using the In-Check™ DIAL. Regression analyses were used to investigate the association between PIF through resistances and spirometric parameters obtained at discharge, comorbidities and demographic parameters.

resultsForty-seven COPD patients (mean [±SD], age 71 [±9] years, 72% males, 51% current smokers) were included in this study. Overall, 85% and 15% were classified as GOLD (2017) groups D and C, respectively. Most prevalent comorbidities were hypertension (70%) and cardiovascular disease (53%). In the final regression model, higher PIF was significantly associated with the following: higher FEV

conclusionThe study did not provide evidence to support the use of surrogate measurements for PIF through device resistance, which could assist in determining the appropriateness of inhaler device type. Although PIF measurement is feasible in patients at discharge and could be a valuable addition to the standard of care in COPD management, it needs to be measured directly.

Indexed as

Airway ResistancePatient AdmissionPatient DischargeSpirometryAdministration, InhalationAgedAged, 80 and overBronchodilator AgentsComorbidityDry Powder InhalersEquipment DesignFeasibility StudiesFemaleForced Expiratory VolumeGreeceHumansBronchodilator AgentsCOPDdry powder inhaler deviceshospital admissioninhaler techniqueresistancespirometry

Identifiers

PMID30587952
PMCPMC6296178
OpenAlexW2904154677

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.